Skip to main content

and
  1. Article

    Open Access

    Insight into the role of p62 in the cisplatin resistant mechanisms of ovarian cancer

    Cisplatin is a platinum-based first-line drug for treating ovarian cancer. However, chemotherapy tolerance has limited the efficacy of cisplatin for ovarian cancer patients. Research has demonstrated that cisp...

    **ao-Yu Yan, **an-Zhi Qu, Long Xu, Si-Hang Yu, Rui Tian in Cancer Cell International (2020)

  2. Article

    Open Access

    Arenobufagin induces MCF-7 cell apoptosis by promoting JNK-mediated multisite phosphorylation of Yes-associated protein

    It has been demonstrated that bufadienolides exert potent anti-cancer activity in various tumor types. However, the mechanisms that underlie their anti-cancer properties remain unclear. Yes-associated protein,...

    Li-Juan Deng, Ming Qi, Qun-Long Peng, Min-Feng Chen, Qi Qi in Cancer Cell International (2018)